Inhibikase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Deficit) - Additional Information (Details)

Stockholders' Equity (Deficit) - Additional Information (Details)			3 Months Ended	9 Months Ended
	May 20, 2024 USD ($) $ / shares shares	Feb. 01, 2024	Mar. 31, 2023 USD ($)	Sep. 30, 2024 USD ($) Vote shares	Sep. 30, 2023 USD ($)
Class Of Stock [Line Items]
Votes per each common stock share \| Vote				1
Common stock shares reserved for issuance				3,337,435
Net proceeds from agent (Private Placement) \| $				$ 110,000,000
Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs \| $			$ 1,000,000	$ 3,793,209	$ 8,543,107
Initial fair value of Warrants \| $			$ 1,800,000
Warrant [Member]
Class Of Stock [Line Items]
Common warrants issued for purchase of common shares	710,000			247,925
Securities purchase agreements [Member] \| Warrant [Member]
Class Of Stock [Line Items]
Issuance of common stock for services, Shares	714,527
Sale of common stock \| $ / shares	$ 1.68
Warrants exercise price \| $ / shares	$ 0.0001
Common warrants issued for purchase of common shares	957,925
Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs \| $	$ 2,200,000
Securities purchase agreements [Member] \| Warrant [Member] \| Series A [Member]
Class Of Stock [Line Items]
Warrants exercise price \| $ / shares	$ 1.68
Common warrants issued for purchase of common shares	1,672,452
Securities purchase agreements [Member] \| Warrant [Member] \| Series B [Member]
Class Of Stock [Line Items]
Warrants exercise price \| $ / shares	$ 1.68
Common warrants issued for purchase of common shares	1,672,452
Warrant Inducement Agreement [Member] \| Series C [Member]
Class Of Stock [Line Items]
Warrants exercise price \| $ / shares	$ 1.68
Common warrants issued for purchase of common shares	1,229,484
Warrant Inducement Agreement [Member] \| Common Stock
Class Of Stock [Line Items]
Warrants exercise price \| $ / shares	$ 1.68
Common warrants issued for purchase of common shares	708,500
Warrant Inducement Agreement [Member] \| Common Stock \| Series C [Member]
Class Of Stock [Line Items]
Common warrants issued for purchase of common shares	708,500
Warrant Inducement Agreement [Member] \| Common Stock \| Series D [Member]
Class Of Stock [Line Items]
Warrants exercise price \| $ / shares	$ 1.68
Common warrants issued for purchase of common shares	708,500
H.C. Wainwright & Co., LLC [Member] \| Wainwright Agreement [Member]
Class Of Stock [Line Items]
Agent commission percentage of aggreagate gross proceeds		3.00%
Number of shares sold				315,338
Net proceeds from agent (Private Placement) \| $				$ 820,509